Publications by authors named "E V Asztalos"
Article Synopsis
- The study investigates the potential link between prenatal exposure to PFAS (per- and polyfluoroalkyl substances) and neurodevelopmental issues in children, using blood samples from 757 pregnant women.
- Results showed that higher maternal PFOA levels were linked to reduced behavioral and social impairments in children, with boys showing more significant associations than girls.
- Overall, the findings suggest weak correlations between prenatal PFAS exposure and neurobehavioral outcomes, indicating that higher exposure may not lead to notable negative developmental issues.
Background: This study aimed to assess the impact of a nutrition-care bundle on growth and neurodevelopmental outcomes of micro-preterm infants born in a level III neonatal intensive care unit (NICU) by two years corrected age.
Methods: A nutrition-care bundle emphasizing the prompt initiation of parenteral nutrition at birth, initiation of enteral feeds within 6 h after birth, and early addition of human milk fortifiers was implemented in 2015 for infants born < 26 weeks gestation. This before-and-after study evaluated growth and neurodevelopmental outcomes in infants born between 2012-2013 (before-nutrition-bundle, BNB) and 2016-2017 (after-nutrition-bundle, ANB).
Background: Immediately after birth, the oxygen saturation is between 30 and 50%, which then increases to 85-95% within the first 10 min. Over the last 10 years, recommendations regarding the ideal level of the initial fraction of inspired oxygen (FiO) for resuscitation in preterm infants have changed from 1.0, to room air to low levels of oxygen (< 0.
View Article and Find Full Text PDFObjective: To compare neurodevelopmental outcomes at 18-24 months corrected age (CA) for preterm infants who had hemoglobin levels <120 g/l versus those with hemoglobin level ≥120 g/l at birth.
Methods: We included infants of ≤28 weeks gestational age (GA) born between January 2009 and June 2018. The primary outcome was neurodevelopmental impairment (NDI) at 18-24 months.